Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2015, Article ID 196297, 13 pages
http://dx.doi.org/10.1155/2015/196297
Research Article

Identification of Anti-Long Chain Saturated Fatty Acid IgG Antibodies in Serum of Patients with Type 2 Diabetes

1Center for Health Disparities and Molecular Medicine, Loma Linda University School of Medicine, 11085 Campus Street, Loma Linda, CA 92350, USA
2Division of Biochemistry, Department of Basic Sciences, Loma Linda University School Medicine, 11085 Campus Street, Loma Linda, CA 92350, USA
3Center for Nutrition, Healthy Lifestyle and Disease Prevention, School of Public Health, Loma Linda University, Sanitarium Drive, Loma Linda, CA 92354, USA
4Section of Endocrinology, JL Pettis Memorial VA Medical Center, 11201 Benton Street, Loma Linda, CA 92357, USA
5Division of Microbiology and Molecular Genetics, Department of Basic Sciences, Loma Linda University School Medicine, 11245 Anderson Street, Loma Linda, CA 92354, USA
6Whittier College, 13406 Philadelphia Street, Whittier, CA 90601, USA
7Department of Physiology and Pharmacology, Loma Linda University School Medicine, 11021 Campus Street, Loma Linda, CA 92350, USA

Received 14 July 2015; Revised 26 September 2015; Accepted 1 October 2015

Academic Editor: Wilco de Jager

Copyright © 2015 Dequina A. Nicholas et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Santos, A. Oliveira, and C. Lopes, “Systematic review of saturated fatty acids on inflammation and circulating levels of adipokines,” Nutrition Research, vol. 33, no. 9, pp. 687–695, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Muñoz and M. Costa, “Nutritionally mediated oxidative stress and inflammation,” Oxidative Medicine and Cellular Longevity, vol. 2013, Article ID 610950, 11 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. A. R. Martins, R. T. Nachbar, R. Gorjao et al., “Mechanisms underlying skeletal muscle insulin resistance induced by fatty acids: importance of the mitochondrial function,” Lipids in Health and Disease, vol. 11, article 30, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. G. Cascio, G. Schiera, and I. di Liegro, “Dietary fatty acids in metabolic syndrome, diabetes and cardiovascular diseases,” Current Diabetes Reviews, vol. 8, no. 1, pp. 2–17, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. N. Esser, S. Legrand-Poels, J. Piette, A. J. Scheen, and N. Paquot, “Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes,” Diabetes Research and Clinical Practice, vol. 105, no. 2, pp. 141–150, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. E. Oliver, F. McGillicuddy, C. Phillips, S. Toomey, and H. M. Roche, “The role of inflammation and macrophage accumulation in the development of obesity-induced type 2 diabetes mellitus and the possible therapeutic effects of long-chain n-3 PUFA,” The Proceedings of the Nutrition Society, vol. 69, no. 2, pp. 232–243, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. B. X. W. Wong, R. A. Kyle, P. C. Myhill et al., “Dyslipidemic diabetic serum increases lipid accumulation and expression of stearoyl-CoA desaturase in human macrophages,” Lipids, vol. 46, no. 10, pp. 931–941, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. E. K. Grishman, P. C. White, and R. C. Savani, “Toll-like receptors, the NLRP3 inflammasome, and interleukin-1beta in the development and progression of type 1 diabetes,” Pediatric Research, vol. 71, no. 6, pp. 626–632, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. T. Kawai and S. Akira, “The role of pattern-recognition receptors in innate immunity: update on toll-like receptors,” Nature Immunology, vol. 11, no. 5, pp. 373–384, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. C. A. Dinarello, M. Y. Donath, and T. Mandrup-Poulsen, “Role of IL-1β in type 2 diabetes,” Current Opinion in Endocrinology, Diabetes and Obesity, vol. 17, no. 4, pp. 314–321, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. J. A. Ehses, G. Lacraz, M.-H. Giroix et al., “IL-1 antagonism reduces hyperglycemia and tissue inflammation in the type 2 diabetic GK rat,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 33, pp. 13998–14003, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. X. Luo, Y. Yang, T. Shen et al., “Docosahexaenoic acid ameliorates palmitate-induced lipid accumulation and inflammation through repressing NLRC4 inflammasome activation in HepG2 cells,” Nutrition & Metabolism, vol. 9, article 34, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Sam and T. Mazzone, “Adipose tissue changes in obesity and the impact on metabolic function,” Translational Research: The Journal of Laboratory and Clinical Medicine, vol. 164, no. 4, pp. 284–292, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. J. M. Olefsky and C. K. Glass, “Macrophages, inflammation, and insulin resistance,” Annual Review of Physiology, vol. 72, pp. 219–246, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Winer and D. A. Winer, “The adaptive immune system as a fundamental regulator of adipose tissue inflammation and insulin resistance,” Immunology and Cell Biology, vol. 90, no. 8, pp. 755–762, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. C. Duffaut, J. Galitzky, M. Lafontan, and A. Bouloumié, “Unexpected trafficking of immune cells within the adipose tissue during the onset of obesity,” Biochemical and Biophysical Research Communications, vol. 384, no. 4, pp. 482–485, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. D. A. Winer, S. Winer, M. H. Y. Chng, L. Shen, and E. G. Engleman, “B Lymphocytes in obesity-related adipose tissue inflammation and insulin resistance,” Cellular and Molecular Life Sciences, vol. 71, no. 6, pp. 1033–1043, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. D. A. Winer, S. Winer, L. Shen et al., “B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies,” Nature Medicine, vol. 17, no. 5, pp. 610–617, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Horváth and A. Bíró, “Anti-cholesterol antibodies in human sera,” Autoimmunity Reviews, vol. 2, no. 5, pp. 272–277, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Amara, C. Chaugier, and M. Geffard, “Autoantibodies directed against conjugated fatty acids in sera of HIV-1-infected patients,” AIDS, vol. 8, no. 5, pp. 711–713, 1994. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Amara, C. Chaugier, J.-M. Ragnaud, and M. Geffard, “Circulating autoantibodies directed against conjugated fatty acids in sera of HIV-1-infected patients,” Clinical and Experimental Immunology, vol. 96, no. 3, pp. 379–383, 1994. View at Google Scholar · View at Scopus
  22. A. I. Boullerne, K. G. Petry, and M. Geffard, “Circulating antibodies directed against conjugated fatty acids in sera of patients with multiple sclerosis,” Journal of Neuroimmunology, vol. 65, no. 1, pp. 75–81, 1996. View at Publisher · View at Google Scholar · View at Scopus
  23. G. Wheeler, S. B. Montgomery, L. Beeson et al., “En Balance: the effects of Spanish diabetes education on physical activity changes and diabetes control,” The Diabetes Educator, vol. 38, no. 5, pp. 723–732, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. R. M. Peterson, L. Beeson, E. Shulz et al., “Impacting obesity and glycemic control using a culturally-sensitive diabetes education program in Hispanic patients with type 2 diabetes,” International Journal of Body Composition Research, vol. 8, no. 3, pp. 85–94, 2010. View at Google Scholar
  25. S. Metghalchi, M. Rivera, L. Beeson et al., “Improved clinical outcomes using a culturally sensitive diabetes education program in a hispanic population,” Diabetes Educator, vol. 34, no. 4, pp. 698–706, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. L. M. Salto, Z. Cordero-MacIntyre, L. Beeson, E. Schulz, A. Firek, and M. de Leon, “En balance participants decrease dietary fat and cholesterol intake as part of a culturally sensitive hispanic diabetes education program,” The Diabetes Educator, vol. 37, no. 2, pp. 239–253, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. E. Ojo, L. Beeson, E. Shulz et al., “Effect of the EnBalance, a culturally and language-sensitive diabetes education program, on dietary changes and plasma lipid profile in Hispanic diabetics,” International Journal of Body Composition Research, vol. 8, supplement, pp. S69–S76, 2010. View at Google Scholar
  28. I. Chukwueke, A. Firek, L. Beeson et al., “The En Balance Spanish diabetes education program improves apolipoproteins, serum glucose and body composition in hispanic diabetics,” Ethnicity & Disease, vol. 22, no. 2, pp. 215–220, 2012. View at Google Scholar · View at Scopus
  29. J. C. Bishop, F. D. J. Dunstan, B. J. Nix, T. M. Reynolds, and A. Swift, “All MoMs are not equal: some statistical properties associated with reporting results in the form of multiples of the median,” American Journal of Human Genetics, vol. 52, no. 2, pp. 425–430, 1993. View at Google Scholar · View at Scopus
  30. P. Yaqoob, “Fatty acids and the immune system: from basic science to clinical applications,” Proceedings of the Nutrition Society, vol. 63, no. 1, pp. 89–104, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. J. B. Dowd and A. E. Aiello, “Socioeconomic differentials in immune response,” Epidemiology, vol. 20, no. 6, pp. 902–908, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. P. A. Sheridan, H. A. Paich, J. Handy et al., “Obesity is associated with impaired immune response to influenza vaccination in humans,” International Journal of Obesity, vol. 36, no. 8, pp. 1072–1077, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. K. M. Young, C. M. Gray, and L.-G. Bekker, “Is obesity a risk factor for vaccine non-responsiveness?” PLoS ONE, vol. 8, no. 12, Article ID e82779, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. H. A. Paich, P. A. Sheridan, J. Handy et al., “Overweight and obese adult humans have a defective cellular immune response to pandemic H1N1 influenza a virus,” Obesity, vol. 21, no. 11, pp. 2377–2386, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. C. Lagathu, L. Yvan-Charvet, J.-P. Bastard et al., “Long-term treatment with interleukin-1beta induces insulin resistance in murine and human adipocytes,” Diabetologia, vol. 49, no. 9, pp. 2162–2173, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. I. C. M. MacLennan, A. Gulbranson-Judge, K.-M. Toellner et al., “The changing preference of T and B cells for partners as T-dependent antibody responses develop,” Immunological Reviews, vol. 156, pp. 53–66, 1997. View at Publisher · View at Google Scholar · View at Scopus